Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New … – SYS




IRVINE, CA — (Marketwired) — 08/12/16 — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is happy to announce the intent to seek out 20 – 25 potential candidates suffering from Asthma/COPD and other critical ailments. These initial patients will receive the New

... read more at: http://news.sys-con.com/node/3893418

by